Dear Patients, Oncology Consultants is proud to announce that Dr. Ngoc Pham has joined the Practice. A Houston native, Dr. Pham earned her medical degree at the University of Texas Health Science Center Houston Medical School. She went on to complete her residency in Radiation Oncology at Baylor College of Medicine. Dr. Pham is board eligible in radiation oncology and she has clinical experience in several areas: gynecology cancer, brachytherapy, brain cancer, colorectal canc
Drinking even a small amount of alcohol raises the risk of health problems, including cancer, according to a new report from the Global Burden of Disease Study. The report, recently published in The Lancet, states that 2.8 million deaths worldwide were attributable to alcohol consumption in 2016. “The health risks associated with alcohol are massive,” said senior author Emmanuela Gakidou, MSC, PhD, of the Institute for Health Metrics and Evaluation at the University of Washin
Both John McCain and Jimmy Carter have contended with brain tumors, but the two political icons have had vastly different treatment results. The Arizona senator died Saturday after a year in treatment while the former president was declared cancer-free just four months after he started therapy in 2015. Click the image to read the full article.
Last year, Charlene Creel said her final goodbyes to her late husband, Tom, on the tranquil waters of the Gulf of Mexico. After mixing his ashes with concrete, his memorial became part of a thriving, underwater reef. Charlene's journey to that point began more than three years ago. She discovered a lump in Tom's groin was melanoma, an aggressive skin cancer. It spread from a spot on his calf. "It wasn’t a mole, it had no color, it had no irregular shape and it didn't appear
A new study offers a glint of hope to people in a desperate situation: Patients with melanoma, the most serious form of skin cancer, that has spread to the brain. A combination of two drugs that activate the immune system shrank brain tumors in many melanoma patients and prolonged life in a study of 94 people at 28 medical centers in the United States. The drugs were ipilimumab (brand name Yervoy) and nivolumab (Opdivo), and they belong to a class called checkpoint inhibitors